Arbor Pharms Llc Drug Patent Portfolio

Arbor Pharms Llc owns 2 orange book drugs protected by 6 US patents Given below is the list of Arbor Pharms Llc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8747894 Effervescent compositions containing N-acetylcysteine 08 May, 2032
Active
US9427421 Effervescent compositions containing N-acetylcysteine 08 May, 2032
Active
US9561204 Effervescent compositions containing N-acetylcysteine 08 May, 2032
Active
US8791153 Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice 12 Oct, 2027
Active
US8927595 Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice 12 Oct, 2027
Active
US6103248 Topical preparation and therapy for head lice 22 May, 2018 Expired


Given below is the list of recent legal activities going on the following drug patents of Arbor Pharms Llc.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 31 Jan, 2022 US8791153
Payment of Maintenance Fee, 4th Year, Large Entity 31 Jul, 2020 US9561204
Payment of Maintenance Fee, 4th Year, Large Entity 29 Jan, 2018 US8791153
Patent Issue Date Used in PTA Calculation 07 Feb, 2017 US9561204
Recordation of Patent Grant Mailed 07 Feb, 2017 US9561204
Email Notification 04 Feb, 2017 US9561204
Mail-Petition Decision - Granted 01 Feb, 2017 US9561204
Petition Decision - Granted 31 Jan, 2017 US9561204
Email Notification 19 Jan, 2017 US9561204
Issue Notification Mailed 18 Jan, 2017 US9561204
Application Is Considered Ready for Issue 29 Dec, 2016 US9561204
Dispatch to FDC 29 Dec, 2016 US9561204
Issue Fee Payment Received 21 Dec, 2016 US9561204
Issue Fee Payment Verified 21 Dec, 2016 US9561204
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 21 Nov, 2016 US9561204


Arbor Pharms Llc's Family Patents

Arbor Pharms Llc drugs have patent protection in a total of 2 countries. It has a significant patent presence in the US with 80.0% of its patents being US patents. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Arbor Pharms Llc Drug List

Given below is the complete list of Arbor Pharms Llc's drugs and the patents protecting them.


1. Cetylev

Cetylev is protected by 3 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8747894 Effervescent compositions containing N-acetylcysteine 08 May, 2032
(7 years from now)
Active
US9427421 Effervescent compositions containing N-acetylcysteine 08 May, 2032
(7 years from now)
Active
US9561204 Effervescent compositions containing N-acetylcysteine 08 May, 2032
(7 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cetylev's drug page


2. Sklice

Sklice is protected by 3 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8791153 Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice 12 Oct, 2027
(3 years from now)
Active
US8927595 Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice 12 Oct, 2027
(3 years from now)
Active
US6103248 Topical preparation and therapy for head lice 22 May, 2018
(6 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sklice's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List